02/02/2015 - 3:22pm

Is Whole Foods looking to get into the health clinic business? 

02/02/2015 - 1:29pm

GlaxoSmithKline is gearing up for a Feb. 4 launch of its Flonase Allergy Relief (fluticasone propionate 50 mcg spray), an over-the-counter nasal spray indicated for relief of all nasal and eye-related allergy symptoms.

02/02/2015 - 1:06pm

The number of nurse practitioners licensed in the United States has nearly doubled over the past 10 years, rising from approximately 106,000 in 2004 to 205,000 as of Dec. 31, 2014, according to data recently released by the American Association of Nurse Practitioners.

02/02/2015 - 12:35pm

The Guardian Life Insurance Company of America, a mutual life insurer and a provider of individual disability income insurance, has announced new options for nurse practitioners and physician assistants interested in individual disability income insurance.

02/02/2015 - 12:28pm

Amid the 50th anniversary of the Nurse Practitioner degree program, the American Association of Nurse Practitioners has launched an integrated multimedia campaign to strengthen public and policymaker awareness of the critical role nurse practitioners play in delivering high-quality, affordable and accessible health care to millions of Americans.

02/02/2015 - 11:23am

TyraTech, a life sciences company focusing on nature-derived insect and parasite control products, recently announced that it has secured product listings for its Vamousse head lice product range, including its Vamousse Treatment mousse and Vamousse Protection shampoo, across Walmart and through Cardinal Health.

02/02/2015 - 10:01am

The National Association of Boards of Pharmacy has issued a report underscoring the need for the .Pharmacy Top-Level Domain Program as a public health initiative to help consumers distinguish legitimate online pharmacies from rogue online drug sellers.

01/30/2015 - 10:25am

BioPlus Specialty Pharmacy announced Thursday that URAC, the largest accrediting body for health care, has once again given BioPlus its seal of approval by accrediting it through an on-site process.

01/30/2015 - 10:21am

Diplomat Pharmacy announced Thursday that the Food and Drug Administration has approved an expanded indication of Imbruvica (ibrutinib) for the treatment of Waldenström’s macroglobulinemia (WM).